BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 18027848)

  • 1. Identification of tumor suppressive activity by irradiation microcell-mediated chromosome transfer and involvement of alpha B-crystallin in nasopharyngeal carcinoma.
    Lung HL; Lo CC; Wong CC; Cheung AK; Cheong KF; Wong N; Kwong FM; Chan KC; Law EW; Tsao SW; Chua D; Sham JS; Cheng Y; Stanbridge EJ; Robertson GP; Lung ML
    Int J Cancer; 2008 Mar; 122(6):1288-96. PubMed ID: 18027848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine mapping of the 11q22-23 tumor suppressive region and involvement of TSLC1 in nasopharyngeal carcinoma.
    Lung HL; Cheng Y; Kumaran MK; Liu ET; Murakami Y; Chan CY; Yau WL; Ko JM; Stanbridge EJ; Lung ML
    Int J Cancer; 2004 Nov; 112(4):628-35. PubMed ID: 15382043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma.
    Hui AB; Lo KW; Kwong J; Lam EC; Chan SY; Chow LS; Chan AS; Teo PM; Huang DP
    Mol Carcinog; 2003 Dec; 38(4):170-8. PubMed ID: 14639656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma.
    Lung HL; Bangarusamy DK; Xie D; Cheung AK; Cheng Y; Kumaran MK; Miller L; Liu ET; Guan XY; Sham JS; Fang Y; Li L; Wang N; Protopopov AI; Zabarovsky ER; Tsao SW; Stanbridge EJ; Lung ML
    Oncogene; 2005 Sep; 24(43):6525-32. PubMed ID: 16007174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monochromosome transfer provides functional evidence for growth-suppressive genes on chromosome 14 in nasopharyngeal carcinoma.
    Cheng Y; Ko JM; Lung HL; Lo PH; Stanbridge EJ; Lung ML
    Genes Chromosomes Cancer; 2003 Aug; 37(4):359-68. PubMed ID: 12800147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosome 14 transfer and functional studies identify a candidate tumor suppressor gene, mirror image polydactyly 1, in nasopharyngeal carcinoma.
    Cheung AK; Lung HL; Ko JM; Cheng Y; Stanbridge EJ; Zabarovsky ER; Nicholls JM; Chua D; Tsao SW; Guan XY; Lung ML
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14478-83. PubMed ID: 19667180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mapping of nasopharyngeal carcinoma tumor-suppressive activity to a 1.8-megabase region of chromosome band 11q13.
    Cheng Y; Chakrabarti R; Garcia-Barcelo M; Ha TJ; Srivatsan ES; Stanbridge EJ; Lung ML
    Genes Chromosomes Cancer; 2002 May; 34(1):97-103. PubMed ID: 11921287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma.
    Liu XQ; Chen HK; Zhang XS; Pan ZG; Li A; Feng QS; Long QX; Wang XZ; Zeng YX
    Int J Cancer; 2003 Aug; 106(1):60-5. PubMed ID: 12794757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A functional investigation of tumor suppressor gene activities in a nasopharyngeal carcinoma cell line HONE1 using a monochromosome transfer approach.
    Cheng Y; Stanbridge EJ; Kong H; Bengtsson U; Lerman MI; Lung ML
    Genes Chromosomes Cancer; 2000 May; 28(1):82-91. PubMed ID: 10738306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome 13q12 region critical for the viability and growth of nasopharyngeal carcinoma hybrids.
    Cheng Y; Lung HL; Wong PS; Hao DC; Man CS; Stanbridge EJ; Lung ML
    Int J Cancer; 2004 Apr; 109(3):357-62. PubMed ID: 14961573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional characterization of THY1 as a tumor suppressor gene with antiinvasive activity in nasopharyngeal carcinoma.
    Lung HL; Cheung AK; Cheng Y; Kwong FM; Lo PH; Law EW; Chua D; Zabarovsky ER; Wang N; Tsao SW; Stanbridge EJ; Lung ML
    Int J Cancer; 2010 Jul; 127(2):304-12. PubMed ID: 19921696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma.
    Lung HL; Lo PHY; Xie D; Apte SS; Cheung AKL; Cheng Y; Law EWL; Chua D; Zeng YX; Tsao SW; Stanbridge EJ; Lung ML
    Int J Cancer; 2008 Jul; 123(2):401-408. PubMed ID: 18449890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
    Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monochromosome transfer and microarray analysis identify a critical tumor-suppressive region mapping to chromosome 13q14 and THSD1 in esophageal carcinoma.
    Ko JM; Chan PL; Yau WL; Chan HK; Chan KC; Yu ZY; Kwong FM; Miller LD; Liu ET; Yang LC; Lo PH; Stanbridge EJ; Tang JC; Srivastava G; Tsao SW; Law S; Lung ML
    Mol Cancer Res; 2008 Apr; 6(4):592-603. PubMed ID: 18403638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor suppressor Alpha B-crystallin (CRYAB) associates with the cadherin/catenin adherens junction and impairs NPC progression-associated properties.
    Huang Z; Cheng Y; Chiu PM; Cheung FM; Nicholls JM; Kwong DL; Lee AW; Zabarovsky ER; Stanbridge EJ; Lung HL; Lung ML
    Oncogene; 2012 Aug; 31(32):3709-20. PubMed ID: 22158051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma.
    Cheung AK; Lung HL; Hung SC; Law EW; Cheng Y; Yau WL; Bangarusamy DK; Miller LD; Liu ET; Shao JY; Kou CW; Chua D; Zabarovsky ER; Tsao SW; Stanbridge EJ; Lung ML
    Cancer Res; 2008 Oct; 68(19):8137-45. PubMed ID: 18829573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.
    Chow LS; Lo KW; Kwong J; To KF; Tsang KS; Lam CW; Dammann R; Huang DP
    Int J Cancer; 2004 May; 109(6):839-47. PubMed ID: 15027117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of LARS2, located at the commonly deleted region 3p21.3, by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
    Zhou W; Feng X; Li H; Wang L; Zhu B; Liu W; Zhao M; Yao K; Ren C
    Acta Biochim Biophys Sin (Shanghai); 2009 Jan; 41(1):54-62. PubMed ID: 19129950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma.
    Or YY; Chung GT; To KF; Chow C; Choy KW; Tong CY; Leung AW; Hui AB; Tsao SW; Ng HK; Yip TT; Busson P; Lo KW
    J Pathol; 2010 Jan; 220(1):97-107. PubMed ID: 19718711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
    Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
    Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.